Narrow Results By
Bill C-45: The Cannabis Act
https://policybase.cma.ca/link/policy13723
Canada’s lower-risk cannabis use guidelines (LRCUG)
https://policybase.cma.ca/link/policy13726
CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval
https://policybase.cma.ca/link/policy10437
CMA response to patented medicines regulations consultations
https://policybase.cma.ca/link/policy13690
CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
https://policybase.cma.ca/link/policy13641
- Date
- 2017-04-07
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
CMA's Submission to the House of Commons Standing Committee on Health: Drug Shortages
https://policybase.cma.ca/link/policy10382
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology - Prescription Pharmaceuticals in Canada: The Post-Approval Monitoring of Prescription Pharmaceuticals
https://policybase.cma.ca/link/policy10631
CMA submission to the study of Bill C-37
https://policybase.cma.ca/link/policy13617
Consultation on the renewal of Federal Tobacco Control Strategy
https://policybase.cma.ca/link/policy13804
- Date
- 2017-04-05
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Excise duty framework for cannabis products
https://policybase.cma.ca/link/policy13799
Mental Health, Mental Illness & Addiction : CMA Submission to the Standing Committee on Social affairs, Science and Technology
https://policybase.cma.ca/link/policy1950
- Last Reviewed
- 2012-03-03
- Date
- 2005-04-20
- Topics
- Population health, health equity, public health
- Pharmaceuticals, prescribing, cannabis, drugs
- Policy Type
- Parliamentary submission
- Last Reviewed
- 2012-03-03
- Date
- 2005-04-20
- Topics
- Population health, health equity, public health
- Pharmaceuticals, prescribing, cannabis, drugs
Documents
Non-prescription availability of low-dose codeine products
https://policybase.cma.ca/link/policy13734
Position statement on prescription drug shortages in Canada
https://policybase.cma.ca/link/policy10756
- Last Reviewed
- 2017-03-04
- Date
- 2013-05-25
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs